These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6194080)

  • 1. [Development of morbidity in hemolytic disease of the newborn after the introduction of immune prophylaxis at the Rostock blood exchange center from 1970 to 1980].
    Roewer J; Eggers H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):455-61. PubMed ID: 6194080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The fight against hemolytic disease of the newborn-- an example of interdisciplinary cooperation].
    Müller S; Roewer J; During R; Hille M; Plath C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):720-4. PubMed ID: 2435640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The number of neonates treated with exchange transfusion for hemolytic disease due to Rh isoimmunization before and after the administration of anti-Rho (D) immunoglobulin prophylactically].
    Hodr R
    Cesk Gynekol; 1986 Mar; 51(2):95-6. PubMed ID: 3006930
    [No Abstract]   [Full Text] [Related]  

  • 4. [Morbus hemolyticus neonatorum (erythroblastosis). 2].
    Gallasch E; Karte H; Koziol D; Stein H
    Med Klin; 1968 Mar; 63(13):481-5. PubMed ID: 5727258
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on manifestations of Rh-related hemolytic disease of the newborn in the years 1974-1989 in the Erfurt district].
    Töpke B; Menzel K; Uhlig R; Pfister U
    Kinderarztl Prax; 1991 Apr; 59(4):111-6. PubMed ID: 1905365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of Rhesus sensitization using anti-D, ten years after initiation of the first studies].
    Schneider J
    Z Geburtshilfe Perinatol; 1972 Feb; 176(1):2-16. PubMed ID: 4553933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of fetal hemolytic disease using plasmapheresis].
    Schwarzlos G; During R; Müller S; Stark KH; Plesse R
    Zentralbl Gynakol; 1989; 111(24):1599-603. PubMed ID: 2624011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successes and failures in rhesus-prophylaxis].
    Speiser P
    Wien Med Wochenschr; 1983 Dec; 133(23-24):595-604. PubMed ID: 6420993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rhesus-caused hemolytic disease of the newborn].
    Halle H
    Zentralbl Gynakol; 1971 Aug; 93(32):1079-88. PubMed ID: 4999888
    [No Abstract]   [Full Text] [Related]  

  • 10. [The prevention of reactions during erythroblastosis prophylaxis with immuno-gamma-globulin (IgG)-anti-D].
    Lipp R
    Munch Med Wochenschr; 1968 Sep; 110(37):2091-4. PubMed ID: 5756478
    [No Abstract]   [Full Text] [Related]  

  • 11. [Obstetrical aspects in successes and failures of rhesus-prophylaxis].
    Reinold E
    Wien Med Wochenschr; 1983 Dec; 133(23-24):610-3. PubMed ID: 6420995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological analysis of anti-A antibodies in relation to the ABO morbus haemolyticus neonatorum.
    Borel JF
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Jan; 132(1):72-92. PubMed ID: 4233278
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differential courses of development in children born with hemolytic disease of newborn].
    Rösler HD; Springstein HJ
    Zentralbl Gynakol; 1988; 110(1):25-34. PubMed ID: 3354275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemolytic disease of the newborn caused by Rh incompatibility from the recent neonatologic viewpoint. I. Development of morbidity in the regions of Erfurt and Suhl following general induction of preventive anti-D therapy].
    Menzel K; Kobelt L; Zimmermann U; Töpke B
    Kinderarztl Prax; 1979 May; 47(5):242-50. PubMed ID: 314017
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pediatric aspects of success and failure of anti-D-prophylaxis].
    Fürnkranz H; Rosenkranz A
    Wien Med Wochenschr; 1983 Dec; 133(23-24):607-10. PubMed ID: 6666162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development and present status of immunoprophylaxis of Rh-sensitization].
    Radzuweit H
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1181-5. PubMed ID: 4994101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemolytic disease of the newborn infant. Occurrence and therapeutic results].
    Aichner R
    Wien Med Wochenschr; 1970 Jul; 120(27):494-7. PubMed ID: 5314307
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of hemolytic disease of the newborn due to anti-Dib antibodies.
    Uchikawa M; Shibata Y; Tohyama H; Mori H; Aisaka K; Nakagawa M
    Vox Sang; 1982 Feb; 42(2):91-2. PubMed ID: 7199783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Rhesus haemolytic disease.
    Br Med J; 1967 Oct; 4(5570):3-4. PubMed ID: 4167366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.